

The monoclonal antibody Itolizumab received authorization to start a phase III clinical trial in Covid-19 patients in the US, Mexico and Brazil, reported on Wednesday Cuba's Center for Molecular Immunology (CIM).
Read more Cuba's medicine will be tested in the US, Mexico and Brazil
Molecular Engineering Laboratory of Santiago de Cuba province. Photo: Betty Beatón Ruiz
Samantha Power, Administrator of the United States Agency for International Development (USAID) — this agency is among the top funding sources for subversion in Cuba —, urged the Cuban government to respect the human rights of rapper Maykel “Osorbo” Castillo who is imprisoned in the province of Pinar del Río waiting for trial.
Page 375 of 479